SRS Capital Advisors »

Oric Pharmaceuticals shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $47k 3.9k 12.00
2024-12-31 $548 68 8.07

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Oric Pharmaceuticals

Nextech Invest
EcoR1 Capital
VR Adviser
Viking Global Investors
Pfizer
BlackRock
Vanguard Group
Sr One Capital Management
Alkeon Capital Management
NEA Management Company
OrbiMed Advisors
Column Group
Vivo Capital
Point72 Asset Management
FMR

View all funds holding Oric Pharmaceuticals